[Regression of Epstein-Barr virus associated lymphoma after methotrexate and cyclosporine A withdrawal in a patient with rheumathoid arthritis].
Doña Naranjo
M A
MA
Unidad de Reumatología, Hospital Juan Ramón Jiménez, Huelva.
Vargas Lebrón
C
C
Riesco Díaz
M
M
D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects*; D020031:Epstein-Barr Virus Infections / Q000150:complications*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016393:Lymphoma, B-Cell / Q000139:chemically induced* / Q000821:virology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000139:chemically induced / Q000821:virology; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D008727:Methotrexate